Patents Examined by Chih-Min Kam
-
Patent number: 8765688Abstract: The present invention relates to the use of special peptides in composition which can be used in particular in hair and skin cosmetics, and to such peptide-containing compositions. In particular, the present invention relates to the use of such peptides as active ingredient for inhibition or treatment of dandruff which does not accumulate in the body or in the environment. Furthermore, the invention relates to the production of such compositions, to the peptides used themselves, to their production and to coding nucleotide sequences for such peptides, to dispensing systems for such peptides and to screening methods for identifying suitable further peptides.Type: GrantFiled: December 19, 2008Date of Patent: July 1, 2014Assignee: BASF SEInventors: Burghard Liebmann, Heike Brüser, Heiko Barg, Daniel Hümmerich, Hubertus Peter Bell
-
Patent number: 8753619Abstract: Compositions provided by mixing a biotin-containing component and an avidin-containing component are useful as an adhesive or sealant for medical/surgical uses.Type: GrantFiled: November 23, 2010Date of Patent: June 17, 2014Assignee: Covidien LPInventors: Ahmad R. Hadba, Joshua B. Stopek
-
Patent number: 8748394Abstract: A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a synthetic apolipoprotein A-1 (Apo A-I) mimetic peptide into a wall of the blood vessel at the particular region, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including a synthetic apolipoprotein A-I (Apo A-I) mimetic peptide, or combination of an Apo A-I synthetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of an endogenous Apo A-I related peptide. A composition including an apolipoprotein A-1 (Apo A-I) synthetic peptide in a form suitable for delivery into a blood vessel, the peptide including an amino acid backbone that has less amino acid residues relative to endogenous Apo A-I and a chimera of helix 1 and helix 9 of Apo A-I.Type: GrantFiled: February 22, 2013Date of Patent: June 10, 2014Assignee: Abbott Cardiovascular Systems Inc.Inventors: Katsuyuki Murase, Li Zhao, Irina Astafieva, Paul M. Consigny
-
Patent number: 8742072Abstract: A biocompatible synthetic bone growth composition comprising a fibrillar collagen component and a calcium phosphate component. The composition is formed into particles, and then formed into a unitary article that may be provided at the site of a skeletal defect. An osteoinductive component may be further added, either before or after forming the unitary article. The composition may be formulated as a paste or putty and facilitates bone growth and/or repair.Type: GrantFiled: March 29, 2010Date of Patent: June 3, 2014Assignee: Zimmer Orthobiologics, Inc.Inventor: Kevin J. Thorne
-
Patent number: 8735100Abstract: Methods to digest carbohydrates, especially lignocelluloses and hemicelluloses, using fungal proteins previously not recognized as having this activity are described.Type: GrantFiled: March 17, 2010Date of Patent: May 27, 2014Assignee: Nederlandse Organisatie Voor Toegepast -Natuurwetenschappelijk Onderzoek TNOInventor: Peter Jan Punt
-
Patent number: 8716441Abstract: The invention relates to Tandem Ubiquitin Affinity Entities (TUBES) which are fusion polypeptides comprising at least two ubiquitin binding domains connected to each other by non-naturally occurring spacer regions. The TUBES are capable of binding with high affinity to ubiquitin and to ubiquitylated polypeptides and are therefore suitable for the purification of ubiquitylated polypeptides from cellular extracts as well as for the identification of new ubiquitylated polypeptides.Type: GrantFiled: February 20, 2009Date of Patent: May 6, 2014Assignee: Centro de Investigation Cooperativa en Biociencias—CIC BIOGUNEInventors: Manuel Salvador Rodriguez Medina, Roland Hjerpe
-
Patent number: 8715755Abstract: Methods for the production of substrate, tuber, and grain compositions containing isomalto-oligosaccharides are described. The methods comprise (a) contacting a substrate, tuber or grain containing ungelatinized starch with a maltogenic enzyme and a starch liquefying enzyme to produce maltose; (b) contacting the maltose with a transglucosidic enzyme, wherein the steps (a) and (b) occur at a temperature less than or at a starch gelatinization temperature; and (c) obtaining a substrate, grain or tuber composition having an enzymatically produced isomalto-oligosaccharide, wherein the oligosaccharide is derived from the grain. The maltogenic enzyme can be either exogenous or endogenous to the grain. The contacting steps can be sequential or concurrent. The present invention also describes flour, oral rehydrating solutions, beer adjuncts, food, feed, beverage additives incorporating the grain compositions made as described.Type: GrantFiled: June 29, 2011Date of Patent: May 6, 2014Assignee: Danisco US Inc.Inventors: Gang Duan, Feng Li, Jayarama K. Shetty, Sridevi Vadakoot
-
Patent number: 8716241Abstract: The present invention provides methods of identifying candidate compounds for the treatment of type I diabetes and also provides methods for treating patients with type I diabetes and for limiting pancreatic beta cell apoptosis. The present invention also provides methods for diagnosing type I diabetes or a propensity to develop type I diabetes and methods for identifying diabetic patients to be treated with anti-apoCIII therapy.Type: GrantFiled: July 5, 2013Date of Patent: May 6, 2014Assignee: BioCrine ABInventor: Per-Olof Berggren
-
Patent number: 8710007Abstract: Methods are described for preventing or reducing ischemia and/or systemic inflammatory response in a patient such as perioperative blood loss and/or systemic inflammatory response in a patient subjected to cardiothoracic surgery, e.g. coronary artery bypass grafting and other surgical procedures, especially when such procedures involve extra-corporeal circulation, such as cardiopulmonary bypass.Type: GrantFiled: November 22, 2010Date of Patent: April 29, 2014Assignee: Dyax Corp.Inventors: Robert C. Ladner, Arthur C. Ley, Shirish Hirani, Anthony Williams
-
Patent number: 8703698Abstract: Peptides and mimetics of selected domains of mammalian serum amyloid A isoform 2.1 (SAA2.1) and compounds and compositions thereof are provided that enhance the effect on macrophage cholesterol ester hydrolase activity and/or inhibit acyl CoA:cholesterol acyl transferase activity. Methods of using these compositions in the treatment and/or prevention of atherosclerosis as well as coronary heart disease and cardiovascular disease are also provided.Type: GrantFiled: February 8, 2010Date of Patent: April 22, 2014Assignee: The University of ChicagoInventors: Robert Kisilevsky, Shui-Pang Tam, John B. Ancsin, Zongchao Jia
-
Patent number: 8703910Abstract: Procedures are described which use solvents to increase the topical insecticidal activity of toxic insect peptides. These procedures comprise drying the peptides, if needed, followed by the addition of either: 1) a polar organic solvent, with or without water, to a dried peptide, or 2) the addition of polar aprotic solvent or other adjuvant to the dried peptide, followed by the addition of either: 1) a polar organic solvent, with or without water, (where a polar aprotic solvent is added first) or 2) a polar aprotic solvent or other adjuvant to the peptide polar organic solvent (where the polar organic solvent is added first), to the peptide formulation.Type: GrantFiled: February 15, 2013Date of Patent: April 22, 2014Assignee: Vestaron CorproationInventors: William Tedford, John McIntyre, Daniel Russell, Peter Carlson
-
Patent number: 8703496Abstract: This invention provides methods of using of the sizes and levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) particles, the ?641 allele of the promoter of the gene encoding apolipoprotein C-3 (APOC-3), the 405 allele of the gene encoding cholesteryl ester transfer protein (CETP), and plasma levels of insulin-like growth factor-1 (IGF-1), adiponectin, CETP and APOC-3, for determining and increasing an individual's likelihood of longevity and of retaining cognitive function during aging, and for determining and decreasing an individual's likelihood of developing a cardiovascular-, metabolic- or age-related disease.Type: GrantFiled: March 15, 2013Date of Patent: April 22, 2014Assignee: Albert Einstein College of Medicine of Yeshiva UniversityInventors: Nir Barzilai, Richard B. Lipton
-
Patent number: 8697382Abstract: An object of the present invention is to provide a method of identifying metallo-?-lactamase-producing bacteria, particularly, a method of conveniently identifying an IMP or VIM type. According to the present invention, there is provided a method of detecting metallo-?-lactamase-producing bacteria, comprising spotting a compound (I) onto a surface of a solid medium coated with the bacteria to be tested, spotting 3 types of ?-lactam agents at 3 respective positions different from the spot of the compound (I), culturing the solid medium, and then detecting the metallo-?-lactamase-producing bacteria based on the shape of an inhibition zone formed around the spot of each of the ?-lactam agents. There is further provided a method of identifying an IMP or VIM type of the metallo-?-lactamase-producing bacteria.Type: GrantFiled: March 31, 2010Date of Patent: April 15, 2014Assignee: Meiji Seika Pharma Co., Ltd.Inventor: Akihiro Morinaka
-
Patent number: 8697380Abstract: The invention relates to a method for selecting compounds having a modulating effect on the activation state of a dimer of VFT-domain proteins expressed in cell membranes present in a measuring medium, said dimer consisting of a first protein and of a second protein, said proteins being identical or different, wherein this method comprises the following steps: (a) labeling the first and second proteins in the N-terminal portion of their VFT domains with the members of a pair of FRET partners, the Förster radius (R0) of said pair being between 20 and 55 ?; (b) measuring the FRET signal in the absence and in the presence of the test compound within a predetermined time window; (c) selecting the test compound as a modulating compound if a difference in FRET signal in the absence and in the presence of test compound is measured in step (b). The invention can be used in the search for new medicaments and new taste modulators.Type: GrantFiled: April 29, 2010Date of Patent: April 15, 2014Assignees: CIS Bio International, Centre National de la Recherche ScientifiqueInventors: Etienne Doumazane, Jurriaan Zwier, Eric Trinquet, Jean-Phillippe Pin
-
Patent number: 8697427Abstract: Disclosed herein are obligate heterotrophic microalgae cells containing an exogenous gene. In some embodiments the gene is a sucrose utilization gene, and further disclosed are methods of manufacturing triglyceride oils using sugar cane or sugar beets as a feedstock in a heterotrophic fermentation. In other embodiments the feedstock is depolymerized cellulosic material. Also disclosed are cells that produce medium chain fatty acids at levels not produced in non-recombinant cells of the same species and genus.Type: GrantFiled: May 23, 2012Date of Patent: April 15, 2014Assignee: Solazyme, Inc.Inventors: Scott Franklin, Aravind Somanchi, Karen Espina, George Rudenko, Penelope Chua
-
Patent number: 8680058Abstract: The present invention relates to targeting peptides capable of specifically binding to microbial organisms (e.g., P. aeruginosa or S. mutans), antimicrobial peptides having antimicrobial activities, and specifically/selectively targeted antimicrobial peptides (STAMPs). In addition, the present invention provides methods of selectively killing or inhibiting microbial organisms by using the peptides or compositions provided by the present invention.Type: GrantFiled: November 2, 2010Date of Patent: March 25, 2014Assignees: The Regents of the University of California, C3 Jian, Inc.Inventors: Randal H. Eckert, Daniel K. Yarbrough, Wenyuan Shi, Maxwell H. Anderson, Fengxia Qi, Jian He, Ian H. McHardy
-
Patent number: 8679824Abstract: The present disclosure relates to fermentation broth formulations containing organic acids and/or organic acid salts, and methods of making and using such formulations.Type: GrantFiled: February 19, 2010Date of Patent: March 25, 2014Assignee: Danisco US Inc.Inventors: Tom Tao Huang, Aaron Kelley, John McLaughlin
-
Patent number: 8680057Abstract: The invention features a tribonectin and a method of tribosupplementation carried out by administering tribonectins directly to an injured or arthritic joint.Type: GrantFiled: May 14, 2012Date of Patent: March 25, 2014Assignee: Rhode Island HospitalInventor: Gregory D. Jay
-
Patent number: 8673362Abstract: The present invention relates to a composition and uses thereof for treatment of damaged tissue comprising at least one essential amino acid in L form and at least one essential lipid; wherein the composition is administered to a mammal suffering from severe tissue damage. The invention further relates to a composition and uses thereof comprising the mixture of one or more free L-amino acids in which the molar ratio of the free L-amino acids corresponds to the molar ratio of amino components in a mammalian tissue protein; and at least one essential lipid.Type: GrantFiled: October 24, 2011Date of Patent: March 18, 2014Assignee: Immunopath Profile, Inc.Inventor: Leonard S. Girsh
-
Patent number: 8672918Abstract: The present embodiments relate to methods and systems for identifying areas of a subject's skin that lack sufficient volume. In some embodiments, this can be used to direct the administration of filler compositions or the application of techniques that increase the volume or firmness of the area. In some embodiments, the methods and systems provide for improved aesthetic benefit as well as suitability for instruction and training. In some embodiments, the methods are especially useful in the administration of dermal fillers to a subject.Type: GrantFiled: June 8, 2007Date of Patent: March 18, 2014Assignee: IPSYRNG Capital Development, LLCInventors: Jennifer Barbour, Martin D. Fisher